This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Baxter International Inc. (NYSE:BAX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation SIGMA Spectrum Infusion Pump with Master Drug Library. Enhancements to the infusion pump include increased capacity of the master drug library, which is safety software that enables a hospital to maintain a customized in-house library of facility-defined dosing parameters for infusions to minimize the likelihood of drug errors during care. In addition, new asset-tracking capabilities will allow hospitals to effectively locate, manage and deploy SIGMA Spectrum inventory, helping to ensure efficient allocation of hospital assets.
Baxter plans to launch the next-generation SIGMA Spectrum with select healthcare facilities beginning in the summer of 2014.
''Clinicians are looking for integrated systems that are efficient and cost effective, and allow hospital staff to focus on providing quality care for patients,'' said Brik Eyre, president of Baxter’s Hospital Products business. ''We are excited to bring the next generation of Baxter’s SIGMA Spectrum Infusion Pump with Master Drug Library and its advanced, patient-centered safety technology to the U.S. marketplace.''
Infusion pumps are used throughout hospitals and other acute and chronic care settings to deliver fluids and medications that save and sustain lives. Baxter’s SIGMA Spectrum Infusion Pump with Master Drug Library provides multiple safety features, including dose error reduction software (DERS) and an automatic default to use of the drug safety library at the initial start of dose programming. It also offers an option for wireless connectivity to integrate data into a hospital's electronic medical record (EMR) system, to facilitate the transfer of data to and from the system for updating drug libraries, and to create continuous quality improvement reports.
The 510(k) clearance of Baxter’s next-generation SIGMA Spectrum Infusion Pump with Master Drug Library builds on the past success of the pump platform, a three-consecutive-year winner of the ''Best in KLAS'' award for Smart Pumps – LVP
1 in the
Best in KLAS Awards: Medical Equipment & Infrastructure Report from 2011 – 2013. The SIGMA Spectrum Infusion System is used in four of
U.S. News & World Report’s 2013-2014 top seven ranked hospitals. Baxter will continue to service SIGMA Spectrum pumps currently in the field.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.